288 related articles for article (PubMed ID: 2730658)
21. Interaction of Eglin c with polymorphonuclear cells: evidence for binding to the cell surface.
Braun NJ; Schnebli HP
Biol Chem Hoppe Seyler; 1987 Feb; 368(2):155-61. PubMed ID: 3566916
[TBL] [Abstract][Full Text] [Related]
22. Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.
Ermolieff J; Boudier C; Laine A; Meyer B; Bieth JG
J Biol Chem; 1994 Nov; 269(47):29502-8. PubMed ID: 7961933
[TBL] [Abstract][Full Text] [Related]
23. An elastase inhibitor from equine leukocyte cytosol belongs to the serpin superfamily. Further characterization and amino acid sequence of the reactive center.
Potempa J; Dubin A; Watorek W; Travis J
J Biol Chem; 1988 May; 263(15):7364-9. PubMed ID: 3366785
[TBL] [Abstract][Full Text] [Related]
24. Survey of plant inhibitors of polymorphonuclear leukocyte elastase, pancreatic elastase, cathepsin G, cathepsin B, Hageman factor fragments, and other serine proteinases.
Hojima Y; Pisano JJ; Cochrane CG
Biochem Pharmacol; 1983 Mar; 32(6):985-90. PubMed ID: 6340694
[TBL] [Abstract][Full Text] [Related]
25. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to human leukocyte elastase, bovine alpha-chymotrypsin and subtilisin Carlsberg: thermodynamic study.
Ascenzi P; Amiconi G; Menegatti E; Guarneri M; Bolognesi M; Schnebli HP
J Enzyme Inhib; 1988; 2(3):167-72. PubMed ID: 3071573
[TBL] [Abstract][Full Text] [Related]
26. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
Yavin EJ; Eisenstein M; Fridkin M
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
[TBL] [Abstract][Full Text] [Related]
27. Synthetic peptides derived from the sequence of human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and human leukocyte cathepsin G.
Yavin EJ; Yan L; Desiderio DM; Fridkin M
Int J Pept Protein Res; 1996 Nov; 48(5):465-76. PubMed ID: 8956080
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin.
Baici A; Diczházi C; Neszmélyi A; Móczár E; Hornebeck W
Biochem Pharmacol; 1993 Nov; 46(9):1545-9. PubMed ID: 8240409
[TBL] [Abstract][Full Text] [Related]
29. Specific inhibition of human granulocyte elastase with peptide aldehydes.
Cs-Szabó G; Széll E; Elödi P
FEBS Lett; 1986 Jan; 195(1-2):265-8. PubMed ID: 3510904
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
31. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human serine proteases by SPAAT, the C-terminal 44-residue peptide from alpha1-antitrypsin.
Niemann MA; Baggott JE; Miller EJ
Biochim Biophys Acta; 1997 Jun; 1340(1):123-30. PubMed ID: 9217022
[TBL] [Abstract][Full Text] [Related]
33. Interactions of serine proteinases with pNiXa, a serpin of Xenopus oocytes and embryos.
Kotyza J; Varghese AH; Korza G; Sunderman FW
Biochim Biophys Acta; 1998 Feb; 1382(2):266-76. PubMed ID: 9540798
[TBL] [Abstract][Full Text] [Related]
34. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of a heptacontapeptide corresponding to the entire amino acid sequence of eglin C.
Okada Y; Tsuboi S; Nagamatsu Y; Yamamoto J
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2902-4. PubMed ID: 2076581
[TBL] [Abstract][Full Text] [Related]
36. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates.
Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC
Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of two protease inhibitors from bovine plasma.
Sinha D; Yang X; Emig F; Kirby EP
J Biochem; 1994 Mar; 115(3):387-91. PubMed ID: 8056747
[TBL] [Abstract][Full Text] [Related]
38. Amino acid-derived phthalimide and saccharin derivatives as inhibitors of human leukocyte elastase, cathepsin G, and proteinase 3.
Groutas WC; Chong LS; Venkataraman R; Kuang R; Epp JB; Houser-Archield N; Huang H; Hoidal JR
Arch Biochem Biophys; 1996 Aug; 332(2):335-40. PubMed ID: 8806743
[TBL] [Abstract][Full Text] [Related]
39. Isoxazoline derivatives as potential inhibitors of the proteolytic enzymes human leukocyte elastase, cathepsin G and proteinase 3: a structure-activity relationship study.
Groutas WC; Venkataraman R; Chong LS; Yoder JE; Epp JB; Stanga MA; Kim EH
Bioorg Med Chem; 1995 Feb; 3(2):125-8. PubMed ID: 7796046
[No Abstract] [Full Text] [Related]
40. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
Petersen LC; Bjørn SE; Olsen OH; Nordfang O; Norris F; Norris K
Eur J Biochem; 1996 Jan; 235(1-2):310-6. PubMed ID: 8631347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
